ADAMS STREET PARTNERS LLC 13D/13G Filings for Corvus Pharmaceuticals, Inc. (CRVS)

ADAMS STREET PARTNERS LLC 13D and 13G filings for Corvus Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-05
10:29 am
Unchanged
2026-01-2313DCorvus Pharmaceuticals, Inc.
CRVS
ADAMS STREET PARTNERS LLC3,275,616
3.900%
0
(Unchanged)
Filing